Simuni, T., Brumm, M. C., Uribe, L., Caspell‐Garcia, C., Coffey, C. S., Siderowf, A., Alcalay, R. N., Trojanowski, J. Q., Shaw, L. M., Seibyl, J., Singleton, A., Toga, A. W., Galasko, D., Foroud, T., Nudelman, K., Tosun‐Turgut, D., Poston, K., Weintraub, D., Mollenhauer, B., Tanner, C. M., Kieburtz, K., Chahine, L. M., Reimer, A., Hutten, S., Bressman, S., Marek, K., & , (2020). clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross‐Sectional Study. Movement disorders, 35(5), 833–844. http://access.bl.uk/ark:/81055/vdc_100102721672.0x00004f